» Articles » PMID: 36506487

First Access to Mental Health Services During COVID-19 Pandemic: A Multicenter Study

Overview
Date 2022 Dec 12
PMID 36506487
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The impact of the COVID-19 pandemic on mental health is complex and affects a broad segment of the population. Several studies indicate that depressive, anxious and post-traumatic symptoms are common in people exposed to SARS-Cov2.

Methods: 458 subjects were recruited during their first consultation in outpatient psychiatric services between June 2020 and October 2021. Post-traumatic, depressive and anxious symptoms were assessed using the Impact of Event Scale-Revised (IES-R), the Beck Depression Inventory Scale-second edition (BDI-II), and  the Self Rating Anxiety Scale (SAS). A specific set of questions was developed, with the aim of evaluating socio-demographic variables and work, environmental and personal characteristics related to the pandemic.

Results: Prevalence rates of clinically significant depressive, anxious and post-traumatic symptoms were 57.6%, 63.5% and 54.8%, respectively. Female gender, worsening of relationship status and financial consequences due to the pandemic were the conditions most strongly associated with the presence of psychopathology.

Limitation: The cross-sectional design of the study doesn't allow an evaluation over time of the sample. No assumption of causality can be made due to the lack of pre-pandemic assessments for the investigated variables.

Conclusions: The impact of the pandemic involves depressive, anxious and post-traumatic dimensions. The investigated psychopathology correlates with several variables expressing the personal and environmental changes that occurred in the population due to the COVID-19 emergency. The study is multicentric and the recruitment of participants was held in a clinical setting, providing a realistic picture of the consequences of the pandemic in clinical practice within mental health services.

References
1.
Fleischmann E, Dalkner N, Fellendorf F, Reininghaus E . Psychological impact of the COVID-19 pandemic on individuals with serious mental disorders: A systematic review of the literature. World J Psychiatry. 2022; 11(12):1387-1406. PMC: 8717042. DOI: 10.5498/wjp.v11.i12.1387. View

2.
Codagnone C, Bogliacino F, Gomez C, Charris R, Montealegre F, Liva G . Assessing concerns for the economic consequence of the COVID-19 response and mental health problems associated with economic vulnerability and negative economic shock in Italy, Spain, and the United Kingdom. PLoS One. 2020; 15(10):e0240876. PMC: 7591048. DOI: 10.1371/journal.pone.0240876. View

3.
Mazza M, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R . Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021; 94:138-147. PMC: 7903920. DOI: 10.1016/j.bbi.2021.02.021. View

4.
Caldiroli A, Capuzzi E, Tringali A, Tagliabue I, Turco M, Fortunato A . The psychopathological impact of the SARS-CoV-2 epidemic on subjects suffering from different mental disorders: An observational retrospective study. Psychiatry Res. 2021; 307:114334. PMC: 8664498. DOI: 10.1016/j.psychres.2021.114334. View

5.
Holmes E, OConnor R, Perry V, Tracey I, Wessely S, Arseneault L . Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science. Lancet Psychiatry. 2020; 7(6):547-560. PMC: 7159850. DOI: 10.1016/S2215-0366(20)30168-1. View